Patents by Inventor Simon AUTHIER

Simon AUTHIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATMENT WITH PEGFILGRASTIM AND ROMIPLOSTIM
    Publication number: 20210015901
    Abstract: The present invention concerns methods comprising co-administration of pegfilgrastim and romiplostim for treatment of diseases and conditions characterized by low neutrophil levels (neutropenia) and/or low platelet levels (thrombocytopenia). The present invention concerns an enhanced effect on neutrophil levels and on platelet levels resulting from co-administration of pegfilgrastim and romiplostim. The present invention further concerns a method of treating a patient who has been exposed to radiation, which comprises administering romiplostim at a dose of about 1 to about 10 ?g/kg. The invention further concerns such methods wherein a single dose of romiplostim is administered to the patient and wherein romiplostim is administered about 24 hours or less after the radiation exposure. The invention further concerns treatment with romiplostim and pegfilgrastim for radiation exposure.
    Type: Application
    Filed: March 11, 2019
    Publication date: January 21, 2021
    Applicant: Amgen Inc.
    Inventors: Ganesh BALASUBRAMANIAN, Deborah I. BUNIN, Polly Y. CHANG, Simon AUTHIER, Sameer V. DOSHI, James BAKKE, Janet GAHAGEN, Karen WONG, Mark FIELDEN